Women with breast cancer are taking their sexual health into their own hands

Publicly released:
International
Photo by sydney Rae on Unsplash
Photo by sydney Rae on Unsplash

Women with breast cancer are following tips and advice from other survivors, or working out for themselves how to cope with sexual dysfunction symptoms during and after treatment. A survey of around 500 women that were members of the popular Breastcancer.org online forum, found that although 44% reported having a significantly worsened sex life post-diagnosis, the majority (57%) said they never discussed the sexual side effects of breast cancer treatment with their doctors. Instead around 35% of participants reported using techniques recommended by a peer or that they discovered themselves in order to improve sexual functioning.

Media release

From: PLOS

Women with breast cancer take sexual health into their own hands

A third of users on online breast cancer support forum describe using peer-recommended or self-discovered techniques to improve sexual functioning

A third of users on a popular breast cancer support forum describe using peer-recommended or self-discovered techniques to improve sexual functioning, according to a study published November 15, 2023 in the open-access journal PLOS ONE by Christiana von Hippel from the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, USA, and colleagues.

Over 75 percent of breast cancer survivors describe experiencing some degree of sexual dysfunction. Commonly prescribed interventions such as vaginal lubricants or numbing creams are only moderately effective, and many women report difficulty in discussing sexual dysfunction with their healthcare provider.

von Hippel and colleagues reached out to members of the popular Breastcancer.org online forum community who were women over 18 years old and diagnosed with Stage I-IV breast cancer. The study survey sought to quantify the frequency of sexual dysfunction in participants and investigate their techniques for improving sexual function.

501 women with a median age of 53 years completed the authors’ online survey. Participants were 70 percent sexually active at the time of survey completion, 69 percent heterosexual, 65 percent partnered, and 71 percent white (though about a quarter of participants provided no information regarding partner status, sexual orientation, or race/ethnicity). 47 percent reported being very or extremely satisfied with their sex lives prior to cancer treatment, and 44 percent reported having a significantly worsened sex life post-diagnosis. Though a quarter of participants reported discussing sexual function concerns with their providers, with vaginal dryness and pain with penetration the most common issues, the majority (57 percent) reported never discussing sexual side effects of breast cancer treatment with their clinicians. 35 percent of participants reported using techniques recommended by a peer or that they discovered themselves in order to improve sexual functioning. The authors found these techniques tended to fall into four main domains: pain reduction (e.g. using coconut oil for lubricant or choosing new positions); intimacy and relationship enhancement (e.g more open communication with partners); desire and arousal enhancement (e.g. solo masturbation or using erotica before partnered sex); and emotional coping (e.g. mindset shifts). 46 percent of participants rated their techniques as moderately or more effective when used in addition to or instead of standard techniques offered by clinicians.

Though the authors note their study may not be widely generalizable because of a lack of diversity in their sample, they encourage providers to initiate conversations around sex with their breast cancer patients and share coping techniques discussed by the participants here.

The authors add: “Women with breast cancer are taking the initiative to fill the gap in their care for sexual symptoms by seeking, innovating, and sharing solutions amongst themselves.”

#####

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference:
PLOS ONE
Research:Paper
Organisation/s: Dana-Farber Cancer Institute, USA
Funder: Dr. von Hippel was supported by the National Cancer Institute (NCI 3R25CA057711). Dr. Dibble was supported by the Helen Gurley Brown Foundation (Helen Gurley Brown Presidential Initiative) at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Partridge receives support from Susan G. Komen and the Breast Cancer Research Foundation (BCRF). Dr. Shoshana Rosenberg reports research funding from the Conquer Cancer Foundation.
Media Contact/s
Contact details are only visible to registered journalists.